Mechanistic determinants of MBNL activity

Nucleic Acids Research

Volumn 44, Issue 21, 2016, Pages 10326-10342

  Sznajder, Lukasz J ^a,b   Michalak, Michalł ^a   Taylor, Katarzyna ^a   Cywoniuk, Piotr ^a   Kabza, Michalł ^a   Wojtkowiak Szlachcic, Agnieszka ^a   Matlłoka, Magdalena ^a,c   Konieczny, Patryk ^a   Sobczak, Krzysztof ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b UNIVERSITY OF FLORIDA   (United States)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLEBLIND LIKE PROTEIN; MUSCLEBLIND LIKE PROTEIN 1; MUSCLEBLIND LIKE PROTEIN 2; MUSCLEBLIND LIKE PROTEIN 3; RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MBNL1 PROTEIN, HUMAN; MBNL3 PROTEIN, HUMAN; PROTEIN BINDING; RNA ISOFORM;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MBNL GENE; PARALOGY; PROTEIN RNA BINDING; TRINUCLEOTIDE REPEAT; BINDING SITE; CELL LINE; CHEMISTRY; EXON; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE MOTIF; POSITION WEIGHT MATRIX; PROTEIN TRANSPORT;

ALTERNATIVE SPLICING; BINDING SITES; CELL LINE; EXONS; HUMANS; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; PROTEIN TRANSPORT; RNA; RNA ISOFORMS; RNA-BINDING PROTEINS;

EID: 85016141603     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw915     Document Type: Article

References (58)

1. Scotti, M.M. and Swanson, M.S. (2016) RNA mis-splicing in disease. Nat. Rev. Genet., 17, 19-32.
2. Pascual, M., Vicente, M., Monferrer, L. and Artero, R. (2006) The Muscleblind family of proteins: An emerging class of regulators of developmentally programmed alternative splicing. Differentiation, 74, 65-80.
3. Kanadia, R., Johnstone, K., Mankodi, A., Lungu, C., Thornton, C., Esson, D., Timmers, A., Hauswirth, W. and Swanson, M. (2003) A muscleblind knockout model for myotonic dystrophy. Science, 302, 1978-1980.
4. Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D.J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C.A. et al. (2014) Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell, 56, 311-322.
5. Wang, E.T., Ward, A.J., Cherone, J.M., Giudice, J., Wang, T.T., Treacy, D.J., Lambert, N.J., Freese, P., Saxena, T., Cooper, T.A. et al. (2015) Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res., 25, 858-871.
6. Wang, E., Cody, N., Jog, S., Biancolella, M., Wang, T., Treacy, D., Luo, S., Schroth, G., Housman, D., Reddy, S. et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell, 150, 710-724.
7. Rau, F., Freyermuth, F., Fugier, C., Villemin, J.-P., Fischer, M.-C., Jost, B., Dembele, D., Gourdon, G., Nicole, A., Duboc, D. et al. (2011) Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat. Struct. Mol. Biol., 18, 840-845.
8. Masuda, A., Andersen, H., Doktor, T., Okamoto, T., Ito, M., Andresen, B. and Ohno, K. (2012) CUGBP1 and MBNL1 preferentially bind to 3 UTRs and facilitate mRNA decay. Sci. Rep., 2, 209.
9. Taliaferro, J.M., Vidaki, M., Oliveira, R., Olson, S., Zhan, L., Saxena, T., Wang, E.T., Graveley, B.R., Gertler, F.B., Swanson, M.S. et al. (2016) Distal alternative last exons localize mRNAs to neural projections. Mol. Cell, 61, 821-833.
10. Fardaei, M., Rogers, M., Thorpe, H., Larkin, K., Hamshere, M., Harper, P. and Brook, J. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet., 11, 805-814.
11. Kanadia, R., Urbinati, C., Crusselle, V., Luo, D., Lee, Y.-J., Harrison, J., Oh, S. and Swanson, M. (2003) Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns, 3, 459-462.
12. Teplova, M. and Patel, D. (2008) Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat. Struct. Mol. Biol., 15, 1343-1351.
13. He, F., Dang, W., Abe, C., Tsuda, K., Inoue, M., Watanabe, S., Kobayashi, N., Kigawa, T., Matsuda, T., Yabuki, T. et al. (2009) Solution structure of the RNA binding domain in the human muscleblind-like protein 2. Protein Sci., 18, 80-91.
14. Goers, E., Purcell, J., Voelker, R., Gates, D. and Berglund, J. (2010) MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res., 38, 2467-2484.
15. Lambert, N., Robertson, A., Jangi, M., McGeary, S., Sharp, P.A. and Burge, C.B. (2014) RNA bind-n-seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins. Mol. Cell, 54, 887-900.
16. Tran, H., Gourrier, N., Lemercier-Neuillet, C., Dhaenens, C.-M., Vautrin, A., Fernandez-Gomez, F., Arandel, L., Carpentier, C., Obriot, H., Eddarkaoui, S. et al. (2011) Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms. J. Biol. Chem., 286, 16435-16446.
17. Terenzi, F. and Ladd, A. (2010) Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol., 7, 43-55.
18. Poulos, M., Batra, R., Li, M., Yuan, Y., Zhang, C., Darnell, R. and Swanson, M. (2013) Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum. Mol. Genet., 22, 3547-3558.
19. Kino, Y., Washizu, C., Kurosawa, M., Oma, Y., Hattori, N., Ishiura, S. and Nukina, N. (2015) Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins. Hum. Mol. Genet., 24, 740-756.
20. Lee, K.-Y., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S., Chamberlain, C., Finn, D., Hong, H. et al. (2013) Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med., 5, 1887-1900.
21. Jog, S., Paul, S., Dansithong, W., Tring, S., Comai, L. and Reddy, S. (2012) RNA splicing is responsive to MBNL1 dose. PLoS One, 7, e48825.
22. Du, H., Cline, M., Osborne, R., Tuttle, D., Clark, T., Donohue, J., Hall, M., Shiue, L., Swanson, M., Thornton, C. et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol., 17, 187-193.
23. Charizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M., Xia, G. et al. (2012) Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron, 75, 437-450.
24. Dansithong, W., Paul, S., Comai, L. and Reddy, S. (2005) MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem., 280, 5773-5780.
25. Sen, S., Talukdar, I., Liu, Y., Tam, J., Reddy, S. and Webster, N. (2010) Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J. Biol. Chem., 285, 25426-25437.
26. Grammatikakis, I., Goo, Y.-H., Echeverria, G. and Cooper, T. (2011) Identification of MBNL1 and MBNL3 domains required for splicing activation and repression. Nucleic Acids Res., 39, 2769-2780.
27. Carpentier, C., Ghanem, D., Fernandez-Gomez, F.J., Jumeau, F., Philippe, J.V., Freyermuth, F., Labudeck, A., Eddarkaoui, S., Dhaenens, C.M., Holt, I. et al. (2014) Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2. Biochim. Biophys. Acta, 1842, 654-664.
28. Fardaei, M., Larkin, K., Brook, J. and Hamshere, M. (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res., 29, 2766-2771.
29. Mankodi, A., Urbinati, C., Yuan, Q., Moxley, R., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M. and Thornton, C. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 10, 2165-2170.
30. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T. et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3 end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
31. Fu, Y.H., Pizzuti, A., Fenwick, R.G. Jr, King, J., Rajnarayan, S., Dunne, P.W., Dubel, J., Nasser, G.A., Ashizawa, T., de Jong, P. et al. (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science, 255, 1256-1258.
32. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., O'Hoy, K. et al. (1992) Myotonic dystrophy mutation: An unstable CTG repeat in the 3 untranslated region of the gene. Science, 255, 1253-1255.
33. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W. and Ranum, L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864-867.
34. Napiera-la, M. and Krzyzosiak, W. (1997) CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins. J. Biol. Chem., 272, 31079-31085.
35. Sobczak, K., de Mezer, M., Michlewski, G., Krol, J. and Krzyzosiak, W. (2003) RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res., 31, 5469-5482.
36. Sobczak, K., Michlewski, G., de Mezer, M., Kierzek, E., Krol, J., Olejniczak, M., Kierzek, R. and Krzyzosiak, W. (2010) Structural diversity of triplet repeat RNAs. J. Biol. Chem., 285, 12755-12764.
37. Jiang, H., Mankodi, A., Swanson, M., Moxley, R. and Thornton, C. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet., 13, 3079-3088.
38. Querido, E., Gallardo, F., Beaudoin, M., Mnard, C. and Chartrand, P. (2011) Stochastic and reversible aggregation of mRNA with expanded CUG-Triplet repeats. J. Cell Sci., 124, 1703-1714.
39. Ho, T., Savkur, R., Poulos, M., Mancini, M., Swanson, M. and Cooper, T. (2005) Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell Sci., 118, 2923-2933.
40. Pettersson, O.J., Aagaard, L., Andrejeva, D., Thomsen, R., Jensen, T.G. and Damgaard, C.K. (2014) DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1. Nucleic Acids Res., 42, 7186-7200.
41. Smith, K., Byron, M., Johnson, C., Xing, Y. and Lawrence, J. (2007) Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains. J. Cell Biol., 178, 951-964.
42. Lin, X., Miller, J., Mankodi, A., Kanadia, R., Yuan, Y., Moxley, R., Swanson, M. and Thornton, C. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
43. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 289, 1769-1773.
44. Chen, C., Sobczak, K., Hoskins, J., Southall, N., Marugan, J., Zheng, W., Thornton, C. and Austin, C. (2012) Two high-Throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1. Anal. Bioanal. Chem., 402, 1889-1898.
45. Wojciechowska, M., Taylor, K., Sobczak, K., Napierala, M. and Krzyzosiak, W.J. (2014) Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1. RNA Biol., 11, 742-754.
46. Philips, A.V. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
47. Hino, S.-I., Kondo, S., Sekiya, H., Saito, A., Kanemoto, S., Murakami, T., Chihara, K., Aoki, Y., Nakamori, M., Takahashi, M. et al. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet., 16, 2834-2843.
48. Rapsomaniki, M.A., Kotsantis, P., Symeonidou, I.E., Giakoumakis, N.N., Taraviras, S. and Lygerou, Z. (2012) easyFRAP: An interactive, easy-To-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics, 28, 1800-1801.
49. Wojtkowiak-Szlachcic, A., Taylor, K., Stepniak-Konieczna, E., Sznajder, L.J., Mykowska, A., Sroka, J., Thornton, C.A. and Sobczak, K. (2015) Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy. Nucleic Acids Res., 43, 3318-3331.
50. Konieczny, P., Stepniak-Konieczna, E. and Sobczak, K. (2014) MBNL proteins and their target RNAs, interaction and splicing regulation. Nucleic Acids Res., 42, 10873-10887.
51. Yuan, Y., Compton, S., Sobczak, K., Stenberg, M., Thornton, C., Griffith, J. and Swanson, M. (2007) Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res., 35, 5474-5486.
52. Mallinjoud, P., Villemin, J.P., Mortada, H., Polay Espinoza, M., Desmet, F.O., Samaan, S., Chautard, E., Tranchevent, L.C. and Auboeuf, D. (2014) Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin. Genome Res., 24, 511-521.
53. Nakamori, M., Sobczak, K., Puwanant, A., Welle, S., Eichinger, K., Pandya, S., Dekdebrun, J., Heatwole, C., McDermott, M., Chen, T. et al. (2013) Splicing biomarkers of disease severity in myotonic dystrophy. Ann. Neurol., 74, 862-872.
54. Pettersson, O.J., Aagaard, L., Jensen, T.G. and Damgaard, C.K. (2015) Molecular mechanisms in DM1-A focus on foci. Nucleic Acids Res., 43, 2433-2441.
55. Purcell, J., Oddo, J., Wang, E. and Berglund, J. (2012) Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events. Mol. Cell. Biol., 32, 4155-4167.
56. Kanadia, R., Shin, J., Yuan, Y., Beattie, S., Wheeler, T., Thornton, C. and Swanson, M. (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. U.S.A., 103, 11748-11753.
57. Chau, A. and Kalsotra, A. (2015) Developmental insights into the pathology of and therapeutic strategies for DM1: back to the basics. Dev. Dyn., 244, 377-390.
58. Licatalosi, D., Mele, A., Fak, J., Ule, J., Kayikci, M., Chi, S., Clark, T., Schweitzer, A., Blume, J., Wang, X. et al. (2008) HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature, 456, 464-469.